The liver X receptors

Current Opinion in Investigational Drugs

Volumn 6, Issue 9, 2005, Pages 934-943

  Lala, Deepak S ^a  

^a PFIZER INC   (United States)

Author keywords

ATP binding cassette transporters; Ligand binding domain; Liver X receptor ; Liver X receptor ; Nuclear receptors; Reverse cholesterol transport

Indexed keywords

22 HYDROXYCHOLESTEROL; 3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CELL NUCLEUS RECEPTOR; CHOLESTEROL; CHOLESTEROL DERIVATIVE; CYTOCHROME P450; FATTY ACID SYNTHASE; G PROTEIN COUPLED RECEPTOR; GELATINASE B; GLUCOSE 6 PHOSPHATE; INTERLEUKIN 1BETA; LIGAND; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LOW DENSITY LIPOPROTEIN RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PYRUVATE KINASE; REGULATOR PROTEIN; REPRESSOR PROTEIN; RETINOID X RECEPTOR; SELECTIVE LIVER X RECEPTOR MODULATOR; STEROID RECEPTOR COACTIVATOR 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DIABETES MELLITUS; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; GENE CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN DOMAIN; PROTEIN FAMILY; REVIEW; SKIN DISEASE;

ALZHEIMER DISEASE; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CHOLESTEROL; DIABETES MELLITUS; DNA-BINDING PROTEINS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SKIN DISEASES; TRIGLYCERIDES;

EID: 24644464248     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Francis GA, Fayard E, Picard F, Auwerx J: Nuclear receptors and the control of metabolism. Annu Rev Physiol (2003) 65:261-311.
2. Enmark E, Gustafsson JA: Comparing nuclear receptors in worms, flies and humans. Trends Pharmacol Sci (2001) 22(12):611-615.
3. McKenna NJ, O'Malley BW: Combinatorial control of gone expression by nuclear receptors and coregulators. Cell (2002) 108(4):465-474.
4. Rosenfeld MG, Glass CK: Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem (2001) 276(40):36865-36868.
5. Smith CL, O'Malley BW: Coregulator function: A key to understanding tissue specificity of selective receptor modulators. Endocr Rev (2004) 25(1):45-71.
6. Nagy L, Schwabe JW: Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci (2004) 29(6):317-324.
7. Shang Y, Brown M: Molecular determinants for the tissue specificity of SERMs. Science (2002) 295(5664):2465-2468.
8. McDonnell DP, Connor CE, Wijayaratne A, Chang CY, Norris JD: Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog Horm Res (2002) 57:295-316.
9. Nettles KW, Greene GL: Ligand control of coregulator recruitment of nuclear receptors. Annu Rev Physiol (2005) 67:309-333.
10. Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, Rosenfeld JM et al: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell (2003) 11(4):1079-1092.
11. Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R: Structural determinants of allosteric, ligand activation in RXR heterodimers. Cell (2004) 116(3):417-429.
12. Lee CH, Olson P, Evans RM: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology (2003) 144(6):2201-2207.
13. Winterfield L, Cather J, Cather J, Menter A: Changing paradigms in dermatology: Nuclear hormone receptors. Clin Dermatol (2003) 21(5):447-454.
14. Schulz M, Eggert M: Novel ligands: Fine tuning the transcriptional activity of the glucocorticoid receptor. Curr Pharm Des (2004) 10(23):2817-2826.
15. Muller G: Medicinal chemistry of target family-directed masterkeys. Drug Disc Today (2003) 8(15):681-691.
16. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev (1995) 9(9):1033-1045.
17. Peet DJ, Janowski BA, Mangelsdorf DJ: The LXRs: A new class of oxysterol receptors. Curr Opin Genet Dev (1998) 8(5):571-575.
18. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, Mangelsdorf DJ: Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc Natl Acad Sci USA (1999) 96(1):266-271.
19. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ: Cholesterol and bile acid metabolism are impaired in mice locking the nuclear oxysterol receptor LXRα. Cell (1998) 93(5):693-704.
20. Collins JL: Therapeutic opportunities for liver X receptor modulators. Curr Opin Drug Discov Dev (2004) 7(5):692-702.
21. Ricote M, Valledor AF, Glass CK: Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: Effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 24(2):230-239.
22. Chen JY, Levy-Wilson B, Goodart S, Cooper AD: Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J Biol Chem (2002) 277(45):42588-42595.
23. Agellon LB, Drover VA, Cheema SK, Gbaguidi GF, Walsh A: Dietary cholesterol falls to stimulate the human cholesterol 7α-hydroxylase gene (CYP7A1) in transgenic mice. J Biol Chem (2002) 277(23):20131-20134.
24. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA: Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-α. Mol Endocrinol (2003) 17(3):386-394.
25. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, Tontonoz P: Autoregulation of the human liver X receptor α promoter. Mol Cell Biol (2001) 21(22):7558-7568.
26. Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C, Lala DS: Induction of human liver X receptor α gene expression via an autoregulatory loop mechanism. Mol Endocrinol (2002) 16(3):506-514.
27. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL: Innate and acquired immunity in atherogenesis. Nat Med (2002) 8(11):1218-1226.
28. Rader DJ: Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol (2003) 92(4A):42J-49J.
29. Oram JF, Lawn RM: ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res (2001) 42(8):1173-1179.
30. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (2000) 289(5484):1524-1529.
31. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, Edwards PA: Regulated expression of the apolipaprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors α and β. J Biol Chem (2002) 277(35):31900-31908.
32. Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kest HR, Mangelsdort DJ, Tontonoz P: LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA (2001) 98(2):507-512.
33. Venkateswaran A, Laffitte BA, Joseph SS, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc Natl Acad Sci USA (2000) 97(22):12097-12102.
34. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdort DJ: Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J Biol Chem (2002) 277(21):18793-18800.
35. Venkateswaran A, Repa JJ, Lobaccaro JM, Bronson A, Mangelsdorf DJ, Edwards PA: Human whita/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem (2000) 275(19):14700-14707.
36. Hubacek JA, Berge KE, Cohen JC, Hobbs HH: Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat (2001) 18(4):359-360.
37. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH: Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem (2003) 278(18):15565-15570.
38. Luo Y, Tall AR: Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest (2000) 105(4):513-520.
39. Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ: Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ. J Biol Chem (2001) 276(46):43018-43024.
40. Goldberg IJ: Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis. J Lipid Res (1996) 37(4):693-707.
41. Weinstock PH, Bisgaier CL, Aalto-Setala K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL: Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest (1995) 96(6):2555-2568.
42. Clee SM, Zhang H, Bissada N, Miao L, Ehrenborg E, Benlian P, Shen GX, Angel A, LeBoeuf RC, Hayden MR: Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice: Modulation by cholesteryl ester transfer protein and dietary status. J Lipid Res (1997) 38(10):2079-2089.
43. Coleman T, Selp RL, Gimble JM, Lee D, Maeda N, Semenkovich CF: COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem (1995) 270(21):12518-12525.
44. Schuster GU, Parini P, Wang L, Alberti S, Steffensen KR, Hansson GK, Angelin B, Gustafsson JA: Accumulation of foam cells in liver X receptor-deficient mice. Circulation (2002) 106(9):1147-1153.
45. Brousseau ME, Schaefer EJ, Wolfe ML, Bloeden LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ: Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med (2004) 350(15):1505-1515.
46. Steinberg D: Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med (2002) 8(11):1211-1217.
47. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation (2002) 105(9):1135-1143.
48. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P: Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med (2003) 9(2):213-219.
49. Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P: Liver X receptor-dependent repression of matrix metalloproteinase-9 expression In macrophages. J Biol Chem (2003) 278(12):10443-10449.
50. Valledor AF, Hsu L-C, Ogawa S, Sawka-Verhelle D, Karin M, Glass CK: Activation of liver X receptors and retinold X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA (2004) 101(51):17813-17818.
51. Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O'Connell RM, Chang G, Saez E, Miller JF, Tontonoz P: LXR-dependent gene expression Is important for macrophage survival and the innate immune response. Cell (2004) 119(2):299-309.
52. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J et al: Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA (2002) 99(11):7604-7609.
53. Tangirala RK, Tsukamoto K, Chun SH, Usher D, Puré E, Rader DJ: Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation (1999) 100(17):1816-1822.
54. Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA: Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration. Proc Natl Acad Sci USA (2002) 99(21):13878-13883.
55. Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, Numerick MJ, Tippin TK, Wilson JG, Winegar DA, Kliewer SA: Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol Endocrinol (2002) 16(6):1378-1385.
56. Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC, Walter M, Roth MG, Lazo JS: The liver X receptor ligand T0901317 decreases amylold β production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem (2005) 260(6):4079-4088.
57. Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA, DeKosky ST, Lazo JS: 22R-hydroxycholesterol and 9- cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion. J Biol Chem (2003) 278(15):13244-13256.
58. Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW: Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels. J Biol Chem (2002) 277(50):48508-48513.
59. Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li SD, Jiang XC, Eacho PI et al: A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem (2004) 88(3):623-634.
60. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, Saez E, Tontonoz P: Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA (2003) 100(9):5419-5424.
61. Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson J-A: Liver X receptors downregulate 11β-hydroxysterold dehydrogenase type 1 expression and activity. Diabetes (2002) 51(8):2426-2433.
62. Stulnig TM, Steffensen KR, Gao H, Reimers M, Dahlman-Wright K, Schuster GU, Gustafsson JA: Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol (2002) 62(6):1299-1305.
63. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA, Miller AR et al: Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem (2003) 278(2):1131-1136.
64. Komuves LG, Schmuth M, Fowler AJ, Elias PM, Hanley K, Man MQ, Moser AH, Lobaccaro JM, Williams ML, Mangelsdorf DJ, Feingold KR: Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-β in murine epidermis. J Invest Dermatol (2002) 118(1):25-34.
65. Fowler AJ, Sheu MY, Schmuth M, Kao J, Fluhr JW, Rhein L, Collins JL, Willson TM, Mangelsdorf DJ, Elias PM, Feingold KR: Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: Liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol (2003) 120(2):246-255.
66. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B: Role of LXRs in control of lipogenesis. Genes Dev (2000) 14(22):2831-2838.
67. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdort DJ: Regulation of mouse sterol regulatory element-binding protein-1c gone (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev (2000) 14(22):2819-2830.
68. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, Tontonoz P: Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem (2002) 277(13):11019-11025.
69. Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P: The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol (2003) 23(6):2182-2191.
70. Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R, Ueda K, Inaba T, Minekura H, Kohama T, Furukawa H: Angptl3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem (2002) 277(37):33742-33748.
71. Inaba T, Matsuda M, Shimamura M, Takei N, Terasaka N, Ando Y, Yasumo H, Koishi R, Makishima M, Shimomura I: Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem (2003) 278(24):21344-21351.
72. Davies JD, Carpenter KL, Challis IR, Figg NL, McNair R, Proudfoot D, Weissberg PL, Shanahan CM: Adipocytic differentiation and liver X receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. J Biol Chem (2005) 280(5):3911-3919.
73. Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Bjorkhem I, Pettersson S, Gustafsson JA: Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice. J Clin Invest (2001) 107(5):565-573.
74. Sporn MB, Suh N, Mangelsdorf DJ: Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs). Trends Mol Med (2001) 7(9):395-400.
75. Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, Elbrecht A, Johnson BA, Zhou G, Doebber TW, Biswas C et al: Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator. Mol Endocrinol (2003) 17(4):662-676.
76. Hu X, Li S, Wu J, Xia C, Lala DS: Liver X receptors interact with corepressors to regulate gene expression. Mol Endocrinol (2003) 17(6):1019-1026.
77. Wagner BL, Valiedor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, Schulman IG, Glass CK: Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol (2003) 23(16):5780-5789.
78. Williams S, Bledsoe RK, Collins JL, Boggs S, Lambert MH, Miller AB, Moore J, McKee DD, Moore L, Nichols J, Parks D et al: X-ray crystal structure of the liver X receptor β ligand binding domain: Regulation by a histidine-tryptophan switch. J Biol Chem (2003) 278(29):27138-27143.
79. Svensson S, Ostberg T, Jacobsson M, Norstrom C, Stefansson K, Hallen D, Johansson IC, Zachrisson K, Ogg D, Jendeberg L: Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand-binding domains in a fully agonistic conformation. EMBO J (2003) 22(18):4625-4633.
80. Pearce KH, Iannone MA, Simmons CA, Gray JG: Discovery of novel nuclear receptor modulating ligands: An integral role for peptide interaction profiling. Drug Discov Today (2004) 9(17):741-751.